A new experimental drug lowered blood pressure and sharply reduced signs of kidney damage in people with chronic kidney ...
Oral presentation highlights efficacy and safety profile of lorundrostat in patients with uncontrolled hypertension and chronic kidney disease – RADNOR, Pa., May 18, 2026 (GLOBE NEWSWIRE) -- Mineralys ...
AstraZeneca’s BAXFENDY™ (baxdrostat) has been approved in the US as a first-in-class aldosterone synthase inhibitor (ASI) for ...
Higher blood pressure during young adulthood is likely linked to a higher risk of heart disease and kidney disease later in life, reinforcing the importance of maintaining healthy blood pressure at ...
Children and adolescents diagnosed with hypertension have a 3-fold higher risk of major adverse kidney events. Even children without pre-existing CKD are at risk. Children and adolescents diagnosed ...
High blood pressure may actually be the body's early warning sign for a hidden problem developing in the kidneys. Since ...
After an impressive phase 3 showing last fall, AstraZeneca’s wager on CinCor Pharma and its aldosterone synthase inhibitor ...
Drinking three or more cups of coffee daily increases kidney dysfunction risk, according to one study. Here, experts explain ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results